Medication Study For Young children with Autism

Last Updated: Thursday, November 12, 2015

Principal Investigator:

Description

A new drug being studied, CM-AT, is based on Curemark’s recent research that showed enzyme deficiencies in some autistic children result in an inability to digest protein. The inability to digest protein affects the production of amino acids, the building blocks of chemicals essential for brain function.

The study involves 9 visits over 12 weeks. Visits may include questionnaires, stool samples, or physical exams at no cost to you.

Your time will be compensated.

Sponsored by Curemark.

Participant Criteria

Children age 3– 8 with autism spectrum disorder

Compensation

Evaluations, study visits, and study drug are provided at no cost. $50 per site visit will be provided.

Visit Requirements

Up to 9 visits to Vanderbilt University

Brochure

Download Brochure

Contact Information

Sarah Marler
615 936 3288
sarah.marler@vanderbilt.edu

Want to Participate in this Study?

Enter your name and contact information and this study's coordinators will contact you if there are openings available.

Your Name: (required)  
Your Email: (required)   
Your Phone Number: (not required)

Also...

To be notified when you are a possible match for a research study looking for participants, register with Vanderbilt's ResearchMatch at the link below.

Research Match
ResearchMatch.org is a free and safe national website that matches research volunteers with researchers looking for participants. Registries for Autism and Intellectual Disabilities are now available on ResearchMatch. Everyone is welcome to join, regardless of age, or condition. Visit www.researchmatch.org to learn more and to join today.